Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease? ; day:24 ; month:6 ; year:2024 ; pages:1-12
Current hypertension reports ; (24.6.2024), 1-12
- Urheber
-
Siddiqui, Rehma
Obi, Yoshitsugu
Dossabhoy, Neville R.
Shafi, Tariq
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11906-024-01314-3
- URN
-
urn:nbn:de:101:1-2409170846033.920108929563
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Siddiqui, Rehma
- Obi, Yoshitsugu
- Dossabhoy, Neville R.
- Shafi, Tariq
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Multilayer network analysis in patients with end-stage kidney disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease
A simplified prediction model for end-stage kidney disease in patients with diabetes
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Multilayer network analysis in patients with end-stage kidney disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease
A simplified prediction model for end-stage kidney disease in patients with diabetes
Fabry Disease Presenting as End-Stage Kidney Disease
Health-related physical fitness in end-stage kidney disease
Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4
Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease
Multilayer network analysis in patients with end-stage kidney disease
Blood Pressure Variability and Frailty in End-Stage Kidney Disease
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
Dysfunction of natural killer cells in end-stage kidney disease on hemodialysis
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline
Urine 6-bromotryptophan: associations with genetic variants and incident end-stage kidney disease